<?xml version="1.0" encoding="UTF-8"?>
<ref id="B100">
 <label>100.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Groneberg</surname>
    <given-names>DA</given-names>
   </name>
   <name>
    <surname>Poutanen</surname>
    <given-names>SM</given-names>
   </name>
   <name>
    <surname>Low</surname>
    <given-names>DE</given-names>
   </name>
   <name>
    <surname>Lode</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Welte</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Zabel</surname>
    <given-names>P</given-names>
   </name>
  </person-group>. 
  <article-title>Treatment and vaccines for severe acute respiratory syndrome</article-title>. 
  <source>Lancet Infect Dis.</source> (
  <year>2005</year>) 
  <volume>5</volume>:
  <fpage>147</fpage>â€“
  <lpage>55</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(05)70022-0</pub-id>
  <?supplied-pmid 15766649?>
  <pub-id pub-id-type="pmid">15766649</pub-id>
 </mixed-citation>
</ref>
